NCT01473628View on ClinicalTrials.gov

Radiation Therapy and Rituximab in Treating Patients With Stage I-II Grade 1 or Grade 2 Follicular Lymphoma

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

May 20, 2013

Primary Completion Date

May 20, 2027

Study Completion Date

May 20, 2027

Conditions
Ann Arbor Stage I Grade 1 Follicular LymphomaAnn Arbor Stage I Grade 2 Follicular LymphomaAnn Arbor Stage II Grade 1 Follicular LymphomaAnn Arbor Stage II Grade 2 Follicular Lymphoma
Interventions
OTHER

Clinical Observation

Undergo observation

RADIATION

Radiation Therapy

Undergo radiation therapy

BIOLOGICAL

Rituximab

Given IV

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER